Long-Term Management of Breast Cancer Bone Metastases: Two Case Reports
Patients with advanced HR+/HER2− breast cancer often experience prolonged disease courses, with bone being a dominant site of metastasis. Bone-targeted agents (BTAs) are recommended to reduce the risk of skeletal-related events (SREs), yet most clinical trials report follow-up durations of less than...
-д хадгалсан:
| Үндсэн зохиолчид: | , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
Wiley
2025-01-01
|
| Цуврал: | International Journal of Breast Cancer |
| Онлайн хандалт: | http://dx.doi.org/10.1155/ijbc/9601887 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|